Enjoy complimentary customisation on priority with our Enterprise License!
The Global Induced Pluripotent Stem Cells Production (iPSCs) Market size is forecast to increase by USD 1.84 billion, at a CAGR of 11.66% between 2023 and 2028.
There has been an increasing adoption of iPSCs in drug discovery and toxicity screening applications. In addition, traditional drug discovery methods often rely on animal models or immortalized cell lines, which may not accurately represent human physiology or predict drug responses in human beings. Moreover, iPSCs offer a more physiologically relevant alternative by allowing researchers to generate human cell-based models that closely resemble the cell types affected by diseases or targeted by drugs. Furthermore, researchers are increasingly turning to iPSC-derived cell models to screen potential drug candidates for efficacy and safety. Hence, such factors are positively impacting the market.
To learn more about this report, Download Report Sample
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.